Adherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study
JMIR Cancer · 2025
DOI: 10.2196/76515 ↗Kurz gefasst
Leitlinie in der Zeitschrift JMIR Cancer, 2025. Verfasst von Ryan J Randle und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Division of Thoracic Surgery, Stanford Medicine, 870 Quarry Rd, Stanford, CA, 94305, United States, 1 (650) 723…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Guideline Adherence, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA.
Abstract (Originalsprache)
Background
Several guidelines recommend posttreatment surveillance for non–small cell lung cancer (NSCLC). However, studies evaluating surveillance patterns often cannot distinguish between imaging ordered for surveillance versus for symptoms suggestive of recurrence. Moreover, early recurrences and other competing events hamper efforts to determine true surveillance rates because of wide variability in reported guideline adherence in clinical practice. Leveraging comprehensive Veterans Health Administration data, we developed a novel competing risks framework to describe the patterns and predictors of NSCLC imaging surveillance.
Objective
This study aims to examine posttreatment surveillance to estimate the true surveillance rates and predictors of guideline-concordant care in patients with early-stage NSCLC.
Methods
The study cohort comprised veterans who were treated for stage 1 to 3 NSCLC between 2008 and 2016 and who survived for ≥6 months. Clinical documents and radiology reports were abstracted for image indication and clinical information. We estimated the cumulative probability of receiving guideline-concordant surveillance, defined as chest computed tomography imaging within 4 to 9 months after treatment, accounting for competing risks and censoring. Multivariable cause-specific Cox regression was used to estimate associations between patient factors and guideline-concordant surveillance, with adjustments made for multiple comparisons.
Results
The cohort consisted of 1888 patients. The mean age of the analysis cohort was 66.4 (SD 7.9) years; 95.9% (1811/1888) of the patients were male, 71.1% (1342/1888) of the patients were White, and 43.1% (814/1888) were married. Of the 1888 patients, 57% (n=1076) presented with stage 1 disease, and the most common treatment modality was surgery alone (n=1068, 56.6%). The most common type of imaging performed during the initial 120- to 270-day window was chest computed tomography (1460/3278, 44.5%). Chest X-rays accounted for 36.3% (1190/3278) of all imaging performed, while the remaining 11.8% (386/3278) and 7.4% (242/3278) were positron emission tomography scans or other imaging modalities, respectively. Compared to the years 2008 to 2010, patients treated for NSCLC from 2014 to 2016 had a significantly higher likelihood of receiving guideline-concordant surveillance (hazard ratio 1.42, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Division of Thoracic Surgery, Stanford Medicine, 870 Quarry Rd, Stanford, CA, 94305, United States, 1 (650) 723-5771.
- VA Puget Sound Health Care System, Seattle, WA, United States.
- VA Palo Alto Health Care System, Palo Alto, CA, United States.
- Department of Radiology, Stanford Medicine, Stanford, CA, United States.
- Department of Medicine, Stanford Medicine, Stanford, CA, United States.
- School of Public Health, University of Washington, Seattle, WA, United States.
ORCID-Profile: Ryan J Randle, Scott V Adams, Zahra Esfahanimonfared, Nicole Lin, Julie Wu, Ann Leung, Steven M Asch, Steven Zeliadt, Alex Sox-Harris, Summer Han, Leah M Backhus
Förderung
- HSRD VA
Zitieren
APA
Randle, R. J., Adams, S. V., Esfahanimonfared, Z., Lin, N., Wu, J., Leung, A., Asch, S. M., Zeliadt, S., Sox-Harris, A., Han, S., & Backhus, L. M. (2025). Adherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study. JMIR Cancer. https://doi.org/10.2196/76515
Vancouver
Randle RJ, Adams SV, Esfahanimonfared Z, Lin N, Wu J, Leung A, et al. Adherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study. JMIR Cancer. 2025. doi:10.2196/76515
BibTeX
@article{Randle2025,
author = {Randle, Ryan J and Adams, Scott V and Esfahanimonfared, Zahra and Lin, Nicole and Wu, Julie and Leung, Ann and Asch, Steven M and Zeliadt, Steven and Sox-Harris, Alex and Han, Summer and Backhus, Leah M},
title = {Adherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study},
journal = {JMIR Cancer},
year = {2025},
doi = {10.2196/76515}
}
EUVIMED